[
  {
    "ts": null,
    "headline": "Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results",
    "summary": "NEW BRUNSWICK, N.J., September 03, 2025--Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, October 14th to review third-quarter results. Joaquin Duato, Chairman and Chief Executive Officer, Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Darren Snellgrove, Vice President, Investor Relations will host the call. The question and answer portion of the call will also include additional members of Johnson & Johnson",
    "url": "https://finnhub.io/api/news?id=078efd0dbb75cff82980c71f2248635aa3518d860bc10a14a510f2c011f0c71d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756934940,
      "headline": "Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results",
      "id": 136641806,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "NEW BRUNSWICK, N.J., September 03, 2025--Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, October 14th to review third-quarter results. Joaquin Duato, Chairman and Chief Executive Officer, Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Darren Snellgrove, Vice President, Investor Relations will host the call. The question and answer portion of the call will also include additional members of Johnson & Johnson",
      "url": "https://finnhub.io/api/news?id=078efd0dbb75cff82980c71f2248635aa3518d860bc10a14a510f2c011f0c71d"
    }
  },
  {
    "ts": null,
    "headline": "Factbox-Global drugmakers rush to boost US presence as tariff threat looms",
    "summary": "But with many countries still engaged in trade talks with the U.S., businesses around the world are hedging their decisions pending more clarity on final tariff rates.  The U.S. drugmaker plans to invest $27 billion to build four new manufacturing facilities over the next five years in the U.S. It aims to announce two of its new site locations this quarter.  The drugmaker plans to raise U.S. investments by 25%, totaling $55 billion, over the next four years.",
    "url": "https://finnhub.io/api/news?id=35abbd617332d141878bb80b64dd0dff91b88df1fc45fda598bd74021d9a119e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756926558,
      "headline": "Factbox-Global drugmakers rush to boost US presence as tariff threat looms",
      "id": 136631118,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "But with many countries still engaged in trade talks with the U.S., businesses around the world are hedging their decisions pending more clarity on final tariff rates.  The U.S. drugmaker plans to invest $27 billion to build four new manufacturing facilities over the next five years in the U.S. It aims to announce two of its new site locations this quarter.  The drugmaker plans to raise U.S. investments by 25%, totaling $55 billion, over the next four years.",
      "url": "https://finnhub.io/api/news?id=35abbd617332d141878bb80b64dd0dff91b88df1fc45fda598bd74021d9a119e"
    }
  },
  {
    "ts": null,
    "headline": "J&J Gears Up for Some Key New Drug Approvals and Launches",
    "summary": "JNJ believes 10 of its new products and pipeline candidates can deliver peak sales of $5 billion, including Talvey, Tecvayli, Imaavy, Caplyta and others.",
    "url": "https://finnhub.io/api/news?id=a8a5730ba2e501e9314437e189fcd95d6828f4c15c021bbf80055f56dfbe0a9c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756911840,
      "headline": "J&J Gears Up for Some Key New Drug Approvals and Launches",
      "id": 136616897,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "JNJ believes 10 of its new products and pipeline candidates can deliver peak sales of $5 billion, including Talvey, Tecvayli, Imaavy, Caplyta and others.",
      "url": "https://finnhub.io/api/news?id=a8a5730ba2e501e9314437e189fcd95d6828f4c15c021bbf80055f56dfbe0a9c"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson (JNJ) Presents At 2025 Wells Fargo Healthcare Conference (Transcript)",
    "summary": "Get insights from J&J MedTechâs 2025 strategy at the Wells Fargo Healthcare Conferenceâ",
    "url": "https://finnhub.io/api/news?id=016183ac7f1a4eea8473ef9b22eeb9c8e9465bfda2d46f962430c31e650eae52",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756910547,
      "headline": "Johnson & Johnson (JNJ) Presents At 2025 Wells Fargo Healthcare Conference (Transcript)",
      "id": 136631302,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Get insights from J&J MedTechâs 2025 strategy at the Wells Fargo Healthcare Conferenceâ",
      "url": "https://finnhub.io/api/news?id=016183ac7f1a4eea8473ef9b22eeb9c8e9465bfda2d46f962430c31e650eae52"
    }
  },
  {
    "ts": null,
    "headline": "3 medtech takeaways from ESC 2025",
    "summary": "Pulsed field ablation and transcatheter aortic valve implants were in focus at the European Society of Cardiology Congress in Madrid.",
    "url": "https://finnhub.io/api/news?id=31d20104570328917761a2b371a276662c3ad5fd1dad36736aa784977cac0e3d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756900800,
      "headline": "3 medtech takeaways from ESC 2025",
      "id": 136616898,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Pulsed field ablation and transcatheter aortic valve implants were in focus at the European Society of Cardiology Congress in Madrid.",
      "url": "https://finnhub.io/api/news?id=31d20104570328917761a2b371a276662c3ad5fd1dad36736aa784977cac0e3d"
    }
  },
  {
    "ts": null,
    "headline": "Why drugmakers may need to borrow from quantum theory to confront tariff and pricing threats",
    "summary": "With so many unknowns surrounding regulatory and policy shifts, pharma companies might need to consider fundamental changes to how they operate, a Deloitte analyst said.",
    "url": "https://finnhub.io/api/news?id=204d16d1f824b99eb40e6b3753f5ea6f7efb7db64652d40ed8435066ccc0e98e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756889552,
      "headline": "Why drugmakers may need to borrow from quantum theory to confront tariff and pricing threats",
      "id": 136615677,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "With so many unknowns surrounding regulatory and policy shifts, pharma companies might need to consider fundamental changes to how they operate, a Deloitte analyst said.",
      "url": "https://finnhub.io/api/news?id=204d16d1f824b99eb40e6b3753f5ea6f7efb7db64652d40ed8435066ccc0e98e"
    }
  }
]